KEGG   PATHWAY: sbq05310
Entry
sbq05310                    Pathway                                
Name
Asthma - Saimiri boliviensis boliviensis (Bolivian squirrel monkey)
Description
Asthma is a complex syndrome with many clinical phenotypes in both adults and children. Its major characteristics include a variable degree of airflow obstruction, bronchial hyperresponsiveness, and airway inflammation. Inhaled allergens encounter antigen presenting cells (APC) that line the airway. Upon recognition of the antigen and activation by APC, naive T cells differentiate into TH2 cells. Activated TH2 stimulate the formation of IgE by B cells. IgE molecules bind to IgE receptors located on mast cells. The crosslinking of mast-cell-bound IgE by allergens leads to the release of biologically active mediators (histamine, leukotrienes) by means of degranulation and, so, to the immediate symptoms of allergy. Mast cells also release chemotactic factors that contribute to the recruitment of inflammatory cells, particularly eosinophils, whose proliferation and differentiation from bone marrow progenitors is promoted by IL-5. The activation of eosinophils leads to release of toxic granules and oxygen free radicals that lead to tissue damage and promote the development of chronic inflammation.
Class
Human Diseases; Immune disease
Pathway map
sbq05310  Asthma
sbq05310

Organism
Saimiri boliviensis boliviensis (Bolivian squirrel monkey) [GN:sbq]
Gene
101053828  HLA class II histocompatibility antigen, DQ beta 1 chain-like isoform X2 [KO:K06752]
101054155  HLA class II histocompatibility antigen, DQ alpha 1 chain-like [KO:K06752]
101053201  HLA class II histocompatibility antigen, DQ beta 1 chain isoform X4 [KO:K06752]
101054478  HLA class II histocompatibility antigen, DQ alpha 2 chain isoform X1 [KO:K06752]
101052879  HLA class II histocompatibility antigen, DRB1-4 beta chain-like [KO:K06752]
101034517  HLA class II histocompatibility antigen, DRB1-4 beta chain-like isoform X1 [KO:K06752]
101041326  HLA class II histocompatibility antigen, DRB1-4 beta chain-like [KO:K06752]
101034208  HLA class II histocompatibility antigen, DRB1-9 beta chain-like [KO:K06752]
101041640  mamu class II histocompatibility antigen, DR alpha chain [KO:K06752]
101038711  HLA class II histocompatibility antigen, DM beta chain isoform X1 [KO:K06752]
104650606  HLA class II histocompatibility antigen, DM alpha chain [KO:K06752]
101039757  HLA class II histocompatibility antigen, DO alpha chain [KO:K06752]
101039220  HLA class II histocompatibility antigen, DP beta 1 chain [KO:K06752]
101040088  HLA class II histocompatibility antigen, DP alpha 1 chain isoform X1 [KO:K06752]
101052651  HLA class II histocompatibility antigen, DQ beta 2 chain-like [KO:K06752]
101052977  H-2 class II histocompatibility antigen, E-S beta chain-like [KO:K06752]
101031681  uncharacterized protein LOC101031681 [KO:K10785]
101038267  IL4; interleukin-4 isoform X1 [KO:K05430]
101051030  CD40LG; CD40 ligand [KO:K03161]
101037196  CD40; tumor necrosis factor receptor superfamily member 5 isoform X1 [KO:K03160]
101040997  LOW QUALITY PROTEIN: putative V-set and immunoglobulin domain-containing protein 7 [KO:K06856]
101054381  putative V-set and immunoglobulin domain-containing-like protein IGHV1OR21-1 [KO:K06856]
101033685  uncharacterized protein LOC101033685 [KO:K06856]
101041646  putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 [KO:K06856]
101051969  FCER1A; high affinity immunoglobulin epsilon receptor subunit alpha [KO:K08089]
101053567  MS4A2; high affinity immunoglobulin epsilon receptor subunit beta [KO:K08090]
101050914  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
101047729  IL9; interleukin-9 [KO:K05432]
101052580  IL10; interleukin-10 [KO:K05443]
101038789  IL13; interleukin-13 [KO:K05435]
101039737  IL5; interleukin-5 [KO:K05428]
101053125  eotaxin [KO:K16597]
101031357  TNF; tumor necrosis factor isoform X2 [KO:K03156]
101043897  IL3; interleukin-3 [KO:K04736]
104650700  PRG2; bone marrow proteoglycan isoform X1 [KO:K10786]
101047687  EPX; eosinophil peroxidase [KO:K10788] [EC:1.11.1.7]
Compound
C00388  Histamine
C00696  Prostaglandin D2
C02166  Leukotriene C4
C04598  2-Acetyl-1-alkyl-sn-glycero-3-phosphocholine
C05951  Leukotriene D4
Reference
  Authors
Busse WW, Lemanske RF Jr.
  Title
Asthma.
  Journal
N Engl J Med 344:350-62 (2001)
DOI:10.1056/NEJM200102013440507
Reference
  Authors
Renauld JC.
  Title
New insights into the role of cytokines in asthma.
  Journal
J Clin Pathol 54:577-89 (2001)
DOI:10.1136/jcp.54.8.577
Reference
  Authors
Romagnani S.
  Title
The role of lymphocytes in allergic disease.
  Journal
J Allergy Clin Immunol 105:399-408 (2000)
DOI:10.1067/mai.2000.104575
Reference
  Authors
Averbeck M, Gebhardt C, Emmrich F, Treudler R, Simon JC.
  Title
Immunologic principles of allergic disease.
  Journal
J Dtsch Dermatol Ges 5:1015-28 (2007)
DOI:10.1111/j.1610-0387.2007.06538.x
Reference
  Authors
Conroy DM, Williams TJ.
  Title
Eotaxin and the attraction of eosinophils to the asthmatic lung.
  Journal
Respir Res 2:150-6 (2001)
DOI:10.1186/rr52
Reference
  Authors
Effros RM, Nagaraj H.
  Title
Asthma: new developments concerning immune mechanisms, diagnosis and treatment.
  Journal
Curr Opin Pulm Med 13:37-43 (2007)
DOI:10.1097/MCP.0b013e3280108757
Reference
  Authors
Barnes PJ.
  Title
Immunology of asthma and chronic obstructive pulmonary disease.
  Journal
Nat Rev Immunol 8:183-92 (2008)
DOI:10.1038/nri2254
Reference
  Authors
Holgate ST, Polosa R.
  Title
Treatment strategies for allergy and asthma.
  Journal
Nat Rev Immunol 8:218-30 (2008)
DOI:10.1038/nri2262
Reference
  Authors
Valenta R.
  Title
The future of antigen-specific immunotherapy of allergy.
  Journal
Nat Rev Immunol 2:446-53 (2002)
DOI:10.1038/nri824
Reference
  Authors
Trivedi SG, Lloyd CM.
  Title
Eosinophils in the pathogenesis of allergic airways disease.
  Journal
Cell Mol Life Sci 64:1269-89 (2007)
DOI:10.1007/s00018-007-6527-y
Reference
  Authors
Heinecke JW.
  Title
Eosinophil-dependent bromination in the pathogenesis of asthma.
  Journal
J Clin Invest 105:1331-2 (2000)
DOI:10.1172/JCI10072
Related
pathway
sbq04060  Cytokine-cytokine receptor interaction
sbq04514  Cell adhesion molecules
sbq04612  Antigen processing and presentation
sbq04630  JAK-STAT signaling pathway
sbq04660  T cell receptor signaling pathway
sbq04662  B cell receptor signaling pathway
sbq04664  Fc epsilon RI signaling pathway
KO pathway
ko05310   
LinkDB

DBGET integrated database retrieval system